Your browser doesn't support javascript.
loading
Pleiotropic Anti-atherosclerotic Effects of PCSK9 InhibitorsFrom Molecular Biology to Clinical Translation.
Karagiannis, Angelos D; Liu, Martin; Toth, Peter P; Zhao, Shijia; Agrawal, Devendra K; Libby, Peter; Chatzizisis, Yiannis S.
Afiliação
  • Karagiannis AD; Cardiovascular Biology and Biomechanics Laboratory, Cardiovascular Division, University of Nebraska Medical Center, 982265 Nebraska Medical Center, Omaha, NE, 68198, USA.
  • Liu M; Cardiovascular Biology and Biomechanics Laboratory, Cardiovascular Division, University of Nebraska Medical Center, 982265 Nebraska Medical Center, Omaha, NE, 68198, USA.
  • Toth PP; CGH Medical Center, Sterling, IL, and Ciccarone Center for the Prevention of Heart Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Zhao S; Cardiovascular Biology and Biomechanics Laboratory, Cardiovascular Division, University of Nebraska Medical Center, 982265 Nebraska Medical Center, Omaha, NE, 68198, USA.
  • Agrawal DK; Department of Clinical and Translational Science, Creighton University School of Medicine, Omaha, NE, USA.
  • Libby P; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Chatzizisis YS; Cardiovascular Biology and Biomechanics Laboratory, Cardiovascular Division, University of Nebraska Medical Center, 982265 Nebraska Medical Center, Omaha, NE, 68198, USA. ychatzizisis@icloud.com.
Curr Atheroscler Rep ; 20(4): 20, 2018 03 10.
Article em En | MEDLINE | ID: mdl-29525934

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aterosclerose / Pró-Proteína Convertase 9 / Inibidores de PCSK9 / Anticolesterolemiantes Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aterosclerose / Pró-Proteína Convertase 9 / Inibidores de PCSK9 / Anticolesterolemiantes Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article